Skip to main content
. 2021 Feb 9;177:1–9. doi: 10.1016/j.ijbiomac.2021.02.071

Fig. 5.

Fig. 5

Diagrammatic representation of the SARS-CoV-2 life cycle depicting different target sites that can be implicated in COVID-19 therapeutics.